Literature DB >> 3209356

Noninvasive continuous monitoring of solid-phase peptide synthesis by acid-base indicator.

V Krchnák, J Vágner, M Lebl.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 3209356     DOI: 10.1111/j.1399-3011.1988.tb01276.x

Source DB:  PubMed          Journal:  Int J Pept Protein Res        ISSN: 0367-8377


× No keyword cloud information.
  10 in total

1.  Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein.

Authors:  Judit Oláh; Orsolya Vincze; Dezsõ Virók; Dóra Simon; Zsolt Bozsó; Natália Tõkési; István Horváth; Emma Hlavanda; János Kovács; Anna Magyar; Mária Szũcs; Ferenc Orosz; Botond Penke; Judit Ovádi
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

2.  Fluorescent and lanthanide labeling for ligand screens, assays, and imaging.

Authors:  Jatinder S Josan; Channa R De Silva; Byunghee Yoo; Ronald M Lynch; Mark D Pagel; Josef Vagner; Victor J Hruby
Journal:  Methods Mol Biol       Date:  2011

3.  Hybridisation based DNA screening on peptide nucleic acid (PNA) oligomer arrays.

Authors:  J Weiler; H Gausepohl; N Hauser; O N Jensen; J D Hoheisel
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

4.  An unusual conformation of γ-melanocyte-stimulating hormone analogues leads to a selective human melanocortin 1 receptor antagonist for targeting melanoma cells.

Authors:  Minying Cai; Magda Stankova; Dhanasekaran Muthu; Alexander Mayorov; Zhehui Yang; Devendra Trivedi; Christopher Cabello; Victor J Hruby
Journal:  Biochemistry       Date:  2013-01-15       Impact factor: 3.162

5.  Comparison of epitope specificity of anti-heat shock protein 60/65 IgG type antibodies in the sera of healthy subjects, patients with coronary heart disease and inflammatory bowel disease.

Authors:  George Füst; Katalin Uray; László Bene; Ferenc Hudecz; István Karádi; Zoltán Prohászka
Journal:  Cell Stress Chaperones       Date:  2011-10-29       Impact factor: 3.667

6.  Potent agonists of the protease activated receptor 2 (PAR2).

Authors:  Scott Boitano; Andrea N Flynn; Stephanie M Schulz; Justin Hoffman; Theodore J Price; Josef Vagner
Journal:  J Med Chem       Date:  2011-02-04       Impact factor: 7.446

7.  Novel toll-like receptor 2 ligands for targeted pancreatic cancer imaging and immunotherapy.

Authors:  Amanda Shanks Huynh; Woo Jin Chung; Hyun-Il Cho; Valerie E Moberg; Esteban Celis; David L Morse; Josef Vagner
Journal:  J Med Chem       Date:  2012-11-08       Impact factor: 7.446

8.  Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin Receptors.

Authors:  Jatinder S Josan; Josef Vagner; Heather L Handl; Rajesh Sankaranarayanan; Robert J Gillies; Victor J Hruby
Journal:  Int J Pept Res Ther       Date:  2008-12       Impact factor: 1.931

9.  New approach for preparation of 2,3,7-trisubstituted 3,4-dihydroisoquinolinone libraries on solid phase.

Authors:  Y Ni; V Krchnak; M Lebl
Journal:  Mol Divers       Date:  2000       Impact factor: 2.943

10.  Design of glycopeptides used to investigate class II MHC binding and T-cell responses associated with autoimmune arthritis.

Authors:  Ida E Andersson; C David Andersson; Tsvetelina Batsalova; Balik Dzhambazov; Rikard Holmdahl; Jan Kihlberg; Anna Linusson
Journal:  PLoS One       Date:  2011-03-15       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.